HUP0001270A2 - Compositions and methods for the treatment and diagnosis of breast cancer - Google Patents
Compositions and methods for the treatment and diagnosis of breast cancerInfo
- Publication number
- HUP0001270A2 HUP0001270A2 HU0001270A HUP0001270A HUP0001270A2 HU P0001270 A2 HUP0001270 A2 HU P0001270A2 HU 0001270 A HU0001270 A HU 0001270A HU P0001270 A HUP0001270 A HU P0001270A HU P0001270 A2 HUP0001270 A2 HU P0001270A2
- Authority
- HU
- Hungary
- Prior art keywords
- diagnosis
- compositions
- treatment
- methods
- breast cancer
- Prior art date
Links
- 206010006187 Breast cancer Diseases 0.000 title 1
- 208000026310 Breast neoplasm Diseases 0.000 title 1
- 238000003745 diagnosis Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 230000000295 complement effect Effects 0.000 abstract 1
- 238000012217 deletion Methods 0.000 abstract 1
- 230000037430 deletion Effects 0.000 abstract 1
- 239000013604 expression vector Substances 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 238000003780 insertion Methods 0.000 abstract 1
- 230000037431 insertion Effects 0.000 abstract 1
- 238000012986 modification Methods 0.000 abstract 1
- 230000004048 modification Effects 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
- 238000003259 recombinant expression Methods 0.000 abstract 1
- 230000000717 retained effect Effects 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Landscapes
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
A new isolated DNA (I) is: (a) any of about 170 sequences given in the specification; (b) a variant of (a) containing one or more nucleotide (nt) substitutions, deletions, insertions and/or modifications of not over 20% of nt present, provided that antigenic and/or immunogenic properties of the encoded polypeptide are retained; or (c) encodes an epitope of the polypeptides (II) encoded by (a). Also new are; (1) DNA or RNA complementary to (I); (2) recombinant expression vector containing (I); (3) host cells containing this vector; (4)polypeptides (II); (5) monoclonal antibodies (MAb) that bind to (II).
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/991,789 US6225054B1 (en) | 1996-01-11 | 1997-12-11 | Compositions and methods for the treatment and diagnosis of breast cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUP0001270A2 true HUP0001270A2 (en) | 2000-07-28 |
Family
ID=25537568
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0001270A HUP0001270A2 (en) | 1997-12-11 | 1998-04-09 | Compositions and methods for the treatment and diagnosis of breast cancer |
Country Status (1)
| Country | Link |
|---|---|
| HU (1) | HUP0001270A2 (en) |
-
1998
- 1998-04-09 HU HU0001270A patent/HUP0001270A2/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Rydlander et al. | Molecular characterization of a tissue‐polypeptide‐specific‐antigen epitope and its relationship to human cytokeratin 18 | |
| ZA95786B (en) | Monoclonal antibodies which bind to tumor rejection antigen precursor mage-1 recombinant mage-1 and mage-1 derived immunogeni peptides | |
| EP0939653A4 (en) | Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody and use as a tumor vaccine and for targeting applications | |
| HK1114636A1 (en) | 1l-17 homologous polypeptides and therapeutic uses thereof | |
| IL193886A (en) | Antibodies that bind to ldcam sequences | |
| BG102983A (en) | Extramembrane protein 106 polypeptide of moraxella catarrhalis, its gene sequence and application | |
| UA40621C2 (en) | monoclonal antibody, hybridoma cell line, polypeptide (VARIANTS), THE DNa FRAGMENT (VARIANTS), PHARMACEUTICAL COMPOSITION, METHOD FOR preparation OF monoclonal antibody | |
| HUT63652A (en) | Process for producing cd44 surface protein variants, dna sequences encoding them and antibodies against them, as well as their application in diagnosis and therapy | |
| GR3020819T3 (en) | Toxoplasma gondii antigen, its production and use | |
| HUP0001270A2 (en) | Compositions and methods for the treatment and diagnosis of breast cancer | |
| CA2353802A1 (en) | New protective antigen of group a streptococci | |
| GR3029608T3 (en) | Epididymis specific polypeptides and their use | |
| IL122884A0 (en) | Enamel matrix related polypeptide | |
| Endo et al. | Two murine monoclonal antibodies against human lung cancer-associated antigens | |
| GB9820002D0 (en) | Novel compounds | |
| HK1037209A1 (en) | Proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses | |
| NZ505350A (en) | DNA encoding a tumour antigen peptide (43 kDa) for diagnosis or treatment of tumours | |
| WO2001053344A3 (en) | Chondromodulin-i related peptide | |
| WO2001089281A3 (en) | Tumor-associated antigen (b132), characterized by seq. id. no. 2 | |
| CA2382302A1 (en) | A nucleic acid and encoding polypeptide for use in inhibiting tumor angiogenesis | |
| NZ536318A (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same |